Compton Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,325
| Closed | -$651K | – | 120 |
|
|
2022
Q1 | $651K | Hold |
1,325
| – | – | 0.18% | 94 |
|
|
2021
Q4 | $614K | Sell |
1,325
-25
| -2% | -$10.5K | 0.16% | 102 |
|
|
2021
Q3 | $503K | Sell |
1,350
-25
| -2% | -$9.5K | 0.15% | 109 |
|
|
2021
Q2 | $525K | Hold |
1,375
| – | – | 0.15% | 104 |
|
|
2021
Q1 | $494K | Hold |
1,375
| – | – | 0.15% | 107 |
|
|
2020
Q4 | $441K | Hold |
1,375
| – | – | 0.15% | 103 |
|
|
2020
Q3 | $369K | Sell |
1,375
-50
| -4% | -$13.5K | 0.14% | 103 |
|
|
2020
Q2 | $375K | Hold |
1,425
| – | – | 0.16% | 97 |
|
|
2020
Q1 | $324K | Hold |
1,425
| – | – | 0.16% | 93 |
|
|
2019
Q4 | $430K | Sell |
1,425
-50
| -3% | -$13.8K | 0.17% | 94 |
|
|
2019
Q3 | $354K | Hold |
1,475
| – | – | 0.15% | 105 |
|
|
2019
Q2 | $416K | Sell |
1,475
-75
| -5% | -$20.5K | 0.18% | 102 |
|
|
2019
Q1 | $445K | Sell |
1,550
-144
| -9% | -$41.6K | 0.19% | 97 |
|
|
2018
Q4 | $445K | Sell |
1,694
-50
| -3% | -$13.7K | 0.21% | 99 |
|
|
2018
Q3 | $478K | Hold |
1,744
| – | – | 0.19% | 102 |
|
|
2018
Q2 | $415K | Hold |
1,744
| – | – | 0.18% | 109 |
|
|
2018
Q1 | $383K | Buy |
1,744
+55
| +3% | +$12.9K | 0.16% | 112 |
|
|
2017
Q4 | $380K | Hold |
1,689
| – | – | 0.16% | 112 |
|
|
2017
Q3 | $321K | Hold |
1,689
| – | – | 0.14% | 118 |
|
|
2017
Q2 | $318K | Buy |
1,689
+64
| +4% | +$11.5K | 0.14% | 118 |
|
|
2017
Q1 | $269K | Hold |
1,625
| – | – | 0.13% | 119 |
|
|
2016
Q4 | $234K | Hold |
1,625
| – | – | 0.12% | 121 |
|
|
2016
Q3 | $204K | Hold |
1,625
| – | – | 0.11% | 128 |
|
|
2016
Q2 | $213K | Sell |
1,625
-125
| -7% | -$17.1K | 0.12% | 130 |
|
|
2016
Q1 | $243K | Sell |
1,750
-10
| -0.6% | -$1.34K | 0.14% | 127 |
|
|
2015
Q4 | $245K | Sell |
1,760
-25
| -1% | -$3.44K | 0.14% | 123 |
|
|
2015
Q3 | $250K | Hold |
1,785
| – | – | 0.09% | 118 |
|
|
2015
Q2 | $293K | Sell |
1,785
-75
| -4% | -$12K | 0.16% | 117 |
|
|
2015
Q1 | $287K | Sell |
1,860
-175
| -9% | -$24.9K | 0.16% | 120 |
|
|
2014
Q4 | $256K | Hold |
2,035
| – | – | 0.14% | 123 |
|
|
2014
Q3 | $243K | Sell |
2,035
-50
| -2% | -$5.74K | 0.13% | 123 |
|
|
2014
Q2 | $224K | Buy |
2,085
+10
| +0.5% | +$1.03K | 0.12% | 129 |
|
|
2014
Q1 | $207K | Buy |
+2,075
| New | +$188K | 0.12% | 133 |
|
|
2013
Q3 | – | Sell |
-3,275
| Closed | -$268K | – | 142 |
|
|
2013
Q2 | $268K | Buy |
+3,275
| New | +$245K | 0.17% | 116 |
|
Other funds holding ELV
Compton Capital Management's ELV Position: Q2 2022 in Review
Compton Capital Management sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 1,325 shares — an estimated $651K sold.
Compton Capital Management first reported a position in ELV in Q2 2013 and held it in 34 quarters. The position peaked at $651K in Q1 2022. 1,442 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Compton Capital Management reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
- Compton Capital Management sold 1,325 Elevance Health shares in Q2 2022, an estimated $651K.
- Compton Capital Management first reported a position in Elevance Health in Q2 2013 and held it in 34 quarters.
- Compton Capital Management's Elevance Health position peaked at $651K in Q1 2022.
- 1,442 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Compton Capital Management's 13F filing for Q2 2022, filed 4 Aug 2022.